Gluteal Permanent Synthetic Filler Disease

2

Review clinical trials related to Gluteal Permanent Synthetic Filler Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Prospective Stage-Stratified Histopathologic Study and Proposed Disease-Evolution Model of Gluteal Permanent Synthetic Filler Complications

This prospective biospecimen cohort will collect and analyze tissue from adults undergoing clinically indicated surgery for gluteal permanent synthetic filler disease. Two blinded pathologists will score foreign material burden, inflammation, fibrosis, necrosis, vascular and lymphatic injury, and deep-tissue involvement. Histopathologic severity will be compared across clinical-radiologic stages and time since injection. The study will propose a cross-sectional disease-evolution framework and assess the reproducibility of the scoring system.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Research IncUpdated: Sep 9, 2026Locations: 1Duration: 1 Year
Eligibility criteria

Prior gluteal injection of a permanent or unknown nonresorbable filler. [+3]

Specimen composed only of scar or skin without tissue from the filler-affected r... [+4]

Status: Not yet recruiting

Prospective Paired Evaluation of Conventional Versus Structured Magnetic Resonance Imaging Interpretation for Preoperative Assessment of Gluteal Permanent Synthetic Filler Disease

This prospective paired diagnostic-impact study will compare conventional qualitative MRI reporting with a new structured anatomic classification in adults undergoing surgery for gluteal permanent synthetic filler disease. The structured report will document material effects across superficial, deep, muscular, regional, lymphatic, and interstitial compartments. Standardized intraoperative mapping will serve as the reference standard. The main outcome is the difference in sensitivity for surgically confirmed compartment involvement

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Research IncUpdated: Sep 8, 2026Duration: 1 Day
Eligibility criteria

Age 18 years or older. [+4]

MRI contraindication or nondiagnostic imaging caused by motion or incomplete ana... [+4]